Valuation: Monogram Technologies Inc.

Market Cap 24Cr 21Cr 20Cr 18Cr 35Cr 2.32TCr 35Cr 235.53Cr 91Cr 1.14TCr 92Cr 90Cr 3.92TCr P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 23Cr 20Cr 18Cr 17Cr 32Cr 2.18TCr 33Cr 220.72Cr 86Cr 1.07TCr 86Cr 84Cr 3.68TCr EV / Sales 2023
25,75,22,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 2.88
Extreme 2.88
6.42
3 years 1.53
Extreme 1.53
6.55
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap.
07/25/07Issuer sale

Director

40,000 0.0984%
07/25/07Issuer sale

Chief Technology Officer

13,12,926 3.2312%
07/25/07Issuer sale

Director

8,000 0.0197%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+106.19%+50.75% 24Cr
+4.20%+3.30%-16.66%+7.03% 12TCr
+2.92%-2.26%+0.67%-11.16% 1.23TCr
+7.83%+4.05%+43.14%+108.31% 807.62Cr
-0.64%+1.67%-48.31%-71.81% 399.99Cr
+1.85%+2.81%+18.98%+40.15% 257.32Cr
-1.23%+3.87%-12.07%-14.48% 186.26Cr
-0.41%+1.29%-5.26%-25.04% 161.6Cr
-3.31%-6.90%+221.83%+153.84% 157.75Cr
Average +1.05%+3.55%+34.28%+26.40% 1.69TCr
Weighted average by Cap. +3.92%+0.21%-9.48%+10.40%

Financials

2023 2024
Net sales 0.36 0.32 0.29 0.27 0.52 34.75 0.53 3.53 1.37 17.04 1.37 1.34 58.73 -
Net income -1.37Cr -1.2Cr -1.1Cr -1.03Cr -1.95Cr -130.85Cr -1.98Cr -13Cr -5.15Cr -64Cr -5.16Cr -5.05Cr -221.16Cr -1.63Cr -1.43Cr -1.31Cr -1.22Cr -2.32Cr -155.44Cr -2.36Cr -16Cr -6.11Cr -76Cr -6.13Cr -6Cr -262.71Cr
Net Debt -1.31Cr -1.14Cr -1.05Cr -98L -1.86Cr -124.68Cr -1.89Cr -13Cr -4.9Cr -61Cr -4.92Cr -4.81Cr -210.73Cr -1.53Cr -1.34Cr -1.23Cr -1.15Cr -2.17Cr -145.9Cr -2.21Cr -15Cr -5.74Cr -72Cr -5.75Cr -5.63Cr -246.59Cr
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
27
  1. Stock Market
  2. Stocks
  3. MGRM Stock